Global fibrin sealants market is expected to reach $1.4 billion by 2027.Global fibrin sealants market is valued approximately at $0.9 billion in 2020 and is anticipated to grow with a healthy growth rate of about 7% over the forecast period 2021-2027. Fibrin sealants refer to a type of surgical formulation which is used for the creation of fibrin clot for wound healing or hemostasis. It comprises of separately packaged human thrombin and human fibrinogen. It is widely adopted to control bleeding during and after a surgery. The global fibrin sealants market is being driven by increase in number of patients with chronic diseases such as cardio vascular diseases, cancers, etc. andrising number of surgical procedures across the globe. Furthermore, advancements in technology will provide new opportunities for the global fibrin sealants industry. According to the American Cancer Society, 17.0 million new cases of cancer were witnessed in 2018 (with 9.5 million deaths) across the globe which is expected to reach 27.5 million new cases (with 16.3 million deaths) by 2040. Such growth in the chronic conditions worldwide would increase the need for surgical procedures which is likely to increase the demand for fibrin sealants and hence would drive the market. However, unfavorable reimbursement policies may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global fibrin sealants market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to factors such as rise in surgical procedures, increase in the patients with chronic diseases, growinggeriatric population, rise in demand for dental surgeries, etc. in the region. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to factors such as increasing demand from developing countries such as China and India, growth in healthcare expenditure, increasing cardiovascular surgeries, rise in government funding, etc. across the region.

Major market player included in this report are:
Baxter
Pfizer Inc.
Takeda Pharmaceutical Company
Johnson & Johnson (Ethicon, Inc.)
Grifols, S.A.
CSL Limited
Vivostat A/S
Stryker
Hemarus
Asahi Kasei Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Dosage Form:
Liquid
Patch
Powder
By Indication:
General Surgery
Cardiovascular Surgery
Wound Management
Orthopedic Surgery
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Fibrin Sealants Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors